Optegra Showcases Drop-Free Cataract Surgery Outcomes

Award-winning Optegra data on drop-free cataract surgery sparks interest at SECOIR 2026

June 11, 2026
2 min

The Ophthalmologist

Overview

Optegra's drop-free cataract surgery program demonstrates improved outcomes with a cystoid macular edema rate of 2.9% and an intraocular pressure rate of 0.52%. These results were presented by Pedro Muel at the 2026 SECOIR meeting, highlighting the potential benefits of eliminating post-operative eye drops.

Background

Cataract surgery is a common procedure with significant implications for patient satisfaction and surgical outcomes. The introduction of drop-free techniques aims to enhance patient convenience and reduce the risk of complications associated with postoperative eye drop administration. Understanding the efficacy of these new approaches is crucial for advancing cataract care.

Data Highlights

Outcome	Drop-Free Surgery	Standard Regime
Cystoid Macular Edema Rate	2.9%	3.55%
Intraocular Pressure Rate	0.52%	0.68%

Key Findings

Drop-free cataract surgery eliminates the need for postoperative eye drops.
Cystoid macular edema rate was 2.9% in drop-free surgery compared to 3.55% in standard protocols.
Intraocular pressure rate was 0.52% for drop-free surgery versus 0.68% for conventional methods.
Over 17,000 NHS patients were treated under this program in the past year.
The approach was well-received at the SECOIR congress, indicating interest in innovative cataract surgery techniques.

Clinical Implications

The findings suggest that drop-free cataract surgery may reduce certain postoperative complications while enhancing patient convenience. This approach could lead to a shift in practice patterns, particularly in regions where traditional methods are prevalent.

Conclusion

Optegra's drop-free cataract surgery program presents promising outcomes that may influence future practices in cataract care. Continued evaluation and discussion of these techniques are essential for their broader adoption.